Clinical trial
Optimize RV Selective Site Pacing Clinical Trial
NCT00422669 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Terminated
Key facts
| NCT number | NCT00422669 |
|---|---|
| Title | Optimize RV Selective Site Pacing Clinical Trial |
| Official title | Optimize RV Selective Site Pacing Clinical Trial |
| Lead sponsor | Medtronic Cardiac Rhythm and Heart Failure, Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Cardiac Pacing, Artificial, Cardiac Pacemaker |
| Intervention type | Device |
| Interventions | Medtronic Dual-Chamber Pacemaker, Medtronic SelectSecure 3830 Lead |
| Enrollment | 205 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Jan 17, 2007 |
| Last update posted | Jan 31, 2013 |
| Countries | Canada, China, Israel, Italy, Qatar, United States |
At a glance
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: